Stomeksa - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 19,650 | 15,200 | 9,915 | 2,023 | - | - | 12,446 | 55,428 |
| Profit before tax | -359 | -1,180 | 688 | -3,306 | -214 | 0 | -1,221 | -3,023 |
| Net profit | -359 | -1,180 | 688 | -3,306 | -214 | 0 | -1,221 | -3,023 |
| Equity | 4,151 | 2,970 | 3,658 | 361 | 147 | 147 | -1,074 | -4,097 |
| Liabilities | 5,457 | 7,454 | 15,224 | 2,062 | 0 | 0 | 2,802 | 6,341 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 9,608 | 10,424 | 18,882 | 2,423 | 147 | 147 | 1,728 | 2,244 |
| Total assets | 9,608 | 10,424 | 18,882 | 2,423 | 147 | 147 | 1,728 | 2,244 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 614 | 5,487 |
| Social insurance contributions | - | - | - | - | - | - | - | 1,250 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -12.3% | -22.6% | -34.8% | -79.6% | - | - | - | +345.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -3.7% | -11.3% | 3.6% | -136.4% | -145.6% | 0.0% | -70.7% | -134.7% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -8.6% | -39.7% | 18.8% | -915.8% | -145.6% | 0.0% | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.8% | -7.8% | 6.9% | -163.4% | - | - | -9.8% | -5.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.8% | -7.8% | 6.9% | -163.4% | - | - | -9.8% | -5.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 1.3 | 2.5 | 4.2 | 5.7 | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 12,008 | 15,200 | 9,915 | 2,023 | - | - | 7,861 | 21,456 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Stomeksa - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-08-23 | 2026-08-23 | 192.11 |
| 2026-08-19 | 2026-08-19 | 192.11 |
| 2026-07-23 | 2026-08-10 | 0.72 |
| 2026-05-18 | 2026-05-20 | 61.61 |
| 2026-05-17 | 2026-05-17 | 251.36 |
| 2026-05-03 | 2026-05-13 | 61.61 |
| 2026-04-27 | 2026-04-29 | 61.61 |
| 2026-04-26 | 2026-04-26 | 61.50 |
| 2026-04-24 | 2026-04-25 | 61.61 |
| 2026-04-20 | 2026-04-23 | 61.50 |
| 2026-03-29 | 2026-04-06 | 0.47 |
| 2026-03-17 | 2026-03-27 | 0.47 |
| 2026-02-18 | 2026-03-11 | 0.47 |
| 2026-01-21 | 2026-02-04 | 0.47 |
| 2025-12-16 | 2025-12-18 | 165.29 |
| 2025-11-18 | 2025-11-23 | 165.52 |
| 2025-10-23 | 2025-11-06 | 0.23 |
| 2025-09-16 | 2025-09-18 | 165.48 |
| 2025-09-07 | 2025-09-09 | 0.19 |
| 2025-08-31 | 2025-09-03 | 0.19 |
| 2025-08-19 | 2025-08-29 | 0.19 |
| 2025-07-24 | 2025-08-11 | 0.19 |
| 2025-07-16 | 2025-07-16 | 110.10 |
| 2025-05-19 | 2025-05-20 | 0.95 |
| 2025-05-16 | 2025-05-18 | 179.93 |
| 2025-05-04 | 2025-05-13 | 0.95 |
| 2025-05-01 | 2025-05-01 | 0.95 |
| 2025-04-24 | 2025-04-29 | 0.95 |
| 2025-02-19 | 2025-02-23 | 179.48 |
| 2025-01-22 | 2025-02-10 | 0.50 |
| 2025-01-16 | 2025-01-20 | 436.64 |
| 2024-11-18 | 2024-11-24 | 155.45 |
| 2024-10-24 | 2024-11-05 | 0.72 |
| 2024-09-17 | 2024-09-19 | 217.68 |
| 2024-08-19 | 2024-09-10 | 62.95 |
| 2024-06-18 | 2024-06-18 | 23.20 |
Stomeksa - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Stomeksa, UAB (code 240735230) is a private limited liability company engaged in dental practice care activities. In 2025, the company generated revenue of EUR 55.4K, which was 345.4% higher than EUR 12.4K in 2024. Even with this strong increase in turnover, the business remained loss-making and reported a net loss of EUR 3.0K, compared with a loss of EUR 1.2K a year earlier. The net profit margin improved from -9.8% in 2024 to -5.5% in 2025, showing a better result relative to revenue, although profitability was still negative. Over the two-year period, revenue rose sharply while losses also widened in absolute terms. The balance sheet remained very small, with total assets of EUR 2.2K at the end of 2025, up from EUR 1.7K in 2024. Equity was negative at EUR 4.1K and liabilities totalled EUR 6.3K, indicating a weak capital structure. Because equity was negative, return and leverage ratios are distorted; revenue per employee stood at EUR 27.7K in 2025.